| Ruthenium-catalyzed azide alkyne cycloaddition reaction: scope, mechanism, and applications JR Johansson, T Beke-Somfai, A Said Stålsmeden, N Kann Chemical reviews 116 (23), 14726-14768, 2016 | 407 | 2016 |
| Transition‐Metal‐Catalyzed Propargylic Substitution N Ljungdahl, N Kann Angewandte Chemie International Edition 48 (4), 642-644, 2009 | 211 | 2009 |
| Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virus A Lundin, R Dijkman, T Bergström, N Kann, B Adamiak, C Hannoun, ... PLoS pathogens 10 (5), e1004166, 2014 | 188 | 2014 |
| Sequential one-pot ruthenium-catalyzed azide− alkyne cycloaddition from primary alkyl halides and sodium azide JR Johansson, P Lincoln, B Nordén, N Kann The Journal of organic chemistry 76 (7), 2355-2359, 2011 | 140 | 2011 |
| Recent applications of polymer supported organometallic catalysts in organic synthesis N Kann Molecules 15 (9), 6306-6331, 2010 | 99 | 2010 |
| New chiral amine ligands in the desymmetrization of prochiral phosphine boranes MJ Johansson, L Schwartz, M Amedjkouh, N Kann Tetrahedron: Asymmetry 15 (22), 3531-3538, 2004 | 83 | 2004 |
| Asymmetric Pauson-Khand Cyclization: A Formal Total Synthesis of Natural Brefeldin A V Bernardes, N Kann, A Riera, A Moyano, MA Pericas, AE Greene The Journal of Organic Chemistry 60 (21), 6670-6671, 1995 | 81 | 1995 |
| New functionalized Horner-Wadsworth-Emmons reagents: useful building blocks in the synthesis of polyunsaturated aldehydes. A short synthesis of (.+-.)-(E, E)-coriolic acid N Kann, T Rein, B Aakermark, P Helquist The Journal of Organic Chemistry 55 (19), 5312-5323, 1990 | 74 | 1990 |
| Modular synthesis of ChiraClick ligands: a library of P-chirogenic phosphines F Dolhem, MJ Johansson, T Antonsson, N Kann Journal of Combinatorial Chemistry 9 (3), 477-486, 2007 | 72 | 2007 |
| Synthesis and characterization of new binuclear Co (0) complexes with diphosphinoamine ligands. A potential approach for asymmetric Pauson− Khand reactions Y Gimbert, F Robert, A Durif, MT Averbuch, N Kann, AE Greene The Journal of Organic Chemistry 64 (10), 3492-3497, 1999 | 72 | 1999 |
| Recent advances in the synthesis of P (III)-chirogenic compounds MJ Johansson, NC Kann Mini-Reviews in Organic Chemistry 1 (3), 233-247, 2004 | 68 | 2004 |
| Asymmetric Horner-Wadsworth-Emmons reactions using meso dialdehydes as substrates N Kann, T Rein The Journal of Organic Chemistry 58 (15), 3802-3804, 1993 | 63 | 1993 |
| An iron carbonyl approach to the influenza neuraminidase inhibitor oseltamivir KM Bromfield, H Gradén, DP Hagberg, T Olsson, N Kann Chemical communications, 3183-3185, 2007 | 57 | 2007 |
| Übergangsmetallkatalysierte propargylische Substitutionen N Ljungdahl, N Kann Angewandte Chemie 121 (4), 652-654, 2009 | 56 | 2009 |
| A biocatalytic route to P-chirogenic compounds by lipase-catalyzed desymmetrization of a prochiral phosphine− borane D Wiktelius, MJ Johansson, K Luthman, N Kann Organic Letters 7 (22), 4991-4994, 2005 | 54 | 2005 |
| Applications of the Nicholas reaction in the synthesis of natural products N Kann Current Organic Chemistry 16 (3), 322-334, 2012 | 46 | 2012 |
| Modular asymmetric synthesis of P-chirogenic β-amino phosphine boranes MJ Johansson, KHO Andersson, N Kann The Journal of Organic Chemistry 73 (12), 4458-4463, 2008 | 46 | 2008 |
| Reagent Control of Geometric Selectivity and Enantiotopic Group Preference in Asymmetric Horner−Wadsworth−Emmons Reactions with meso-Dialdehydes JS Tullis, L Vares, N Kann, PO Norrby, T Rein The Journal of Organic Chemistry 63 (23), 8284-8294, 1998 | 39 | 1998 |
| Heterobimetallic gold-iridium, silver-iridium, and gold-ruthenium bis (. mu.-hydrido) complexes. X-ray crystal and molecular structures of [AuRu (H) 2 (dppm) 2 (PPh3)] PF6 and … BD Alexander, BJ Johnson, SM Johnson, PD Boyle, NC Kann, ... Inorganic Chemistry 26 (21), 3506-3513, 1987 | 39 | 1987 |
| Two novel fusion inhibitors of human respiratory syncytial virus A Lundin, T Bergström, L Bendrioua, N Kann, B Adamiak, E Trybala Antiviral research 88 (3), 317-324, 2010 | 35 | 2010 |
Magnus j JohanssonVerified email at astrazeneca.com
